Novel and Emerging Drugs for Chronic Lymphocytic Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|5|471-483

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.5, 2012-05, pp. : 471-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for chronic lymphocytic leukaemia

By Yee Karen WL   O’Brien Susan M  

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 167-189

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for chronic myeloid leukemia

By Cilloni Daniela   Messa Emanuela   Rotolo Antonia   Saglio Giuseppe  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 175-184

Informa Healthcare

Access to resources Recommend Favorite

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

By  

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 156-171

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia

By Balakrishnan Kumudha   Gandhi Varsha  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 409-423

Informa Healthcare

Access to resources Recommend Favorite

Novel and Emerging Drugs for Acute Lymphoblastic Leukemia

By  

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 505-521

Bentham Science Publishers

Access to resources Recommend Favorite